Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.7 EUR | +2.39% |
|
+9.00% | +0.18% |
Jul. 01 | US FDA Approves Formycon's Biosimilar to Treat Serious Retinal Diseases | MT |
Jun. 18 | Borse Frankfurt-News: Many winners and many losers (second-line stocks) | DP |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FORMYCON AG | Other Biotechnology & Medical Research | +2.39% | +9.00% | - | - | - | 1.07B | - | - | - |
- Stock Market
- Equities
- FYB Stock
- FYB Stock
- Charts Formycon AG
- Relative Strength Chart